Skip to main content

Advertisement

Log in

Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn’s disease

  • Correspondence
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Brooklyn TN, Dunnill MG, Shetty A et al (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomized, double blind, placebo controlled trial. Gut 55:505–509

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Wallace HJ, Stacey MC (1998) Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol 110:292–296

    Article  PubMed  CAS  Google Scholar 

  3. Teich N, Klugmann T (2014) Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis. J Crohns Colitis 8:85–86

    Article  PubMed  Google Scholar 

  4. Streit M, Beleznay Z, Braathen LR (2006) Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds. Int Wound J 3:171–179

    Article  PubMed  Google Scholar 

  5. Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M (2014) Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis 20:213–227

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Teich.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teich, N. Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn’s disease. Tech Coloproctol 18, 965–966 (2014). https://doi.org/10.1007/s10151-014-1192-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-014-1192-2

Keywords

Navigation